Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19

Luke Milross; Bethany Hunter; David McDonald; George Merces; Amanda Thompson; Catharien M.U. Hilkens; John Wills; Paul Rees; Kasim Jiwa; Nigel Cooper; Joaquim Majo; Helen Ashwin; Christopher J.A. Duncan; Paul M. Kaye; Omer Ali Bayraktar; Andrew Filby; Andrew J. Fisher

doi:10.1101/2023.05.05.23289594

Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19

View ORCID ProfileLuke Milross, View ORCID ProfileBethany Hunter, David McDonald, George Merces, Amanda Thompson, View ORCID ProfileCatharien M.U. Hilkens, John Wills, View ORCID ProfilePaul Rees, Kasim Jiwa, Nigel Cooper, Joaquim Majo, Helen Ashwin, View ORCID ProfileChristopher J.A. Duncan, View ORCID ProfilePaul M. Kaye, View ORCID ProfileOmer Ali Bayraktar, View ORCID ProfileAndrew Filby, Andrew J. Fisher

doi: https://doi.org/10.1101/2023.05.05.23289594

Luke Milross

1Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Luke Milross

Bethany Hunter

2Newcastle University Biosciences Institute, Newcastle upon Tyne, UK

3Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Bethany Hunter

David McDonald

2Newcastle University Biosciences Institute, Newcastle upon Tyne, UK

3Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

George Merces

2Newcastle University Biosciences Institute, Newcastle upon Tyne, UK

3Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Amanda Thompson

1Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK

2Newcastle University Biosciences Institute, Newcastle upon Tyne, UK

3Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Catharien M.U. Hilkens

1Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Catharien M.U. Hilkens

John Wills

4Department of Veterinary Medicine, University of Cambridge, Cambridge, UK

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Paul Rees

5Department of Biomedical Engineering, Swansea University, Wales, UK

6Imaging Platform, Broad Institute of MIT and Harvard, 415 Main Street, Boston, Cambridge, MA, USA

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Paul Rees

Kasim Jiwa

7Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nigel Cooper

7Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Joaquim Majo

7Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Helen Ashwin

8York Biomedical Research Institute, Hull York Medical School, University of York, York, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christopher J.A. Duncan

1Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK

9Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

DPhil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Christopher J.A. Duncan

Paul M. Kaye

8York Biomedical Research Institute, Hull York Medical School, University of York, York, UK

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Paul M. Kaye

Omer Ali Bayraktar

10Wellcome Sanger Institute, Hinxton, Cambridge, UK

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Omer Ali Bayraktar

Andrew Filby

2Newcastle University Biosciences Institute, Newcastle upon Tyne, UK

3Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Andrew Filby
For correspondence: a.j.fisher@newcastle.ac.uk andrew.filby@newcastle.ac.uk

Andrew J. Fisher

1Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK

11Institute of Transplantation, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

PhD FRCP

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: a.j.fisher@newcastle.ac.uk andrew.filby@newcastle.ac.uk

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Supplemental Tables and Figures[supplements/289594_file03.pdf]

View the discussion thread.

PreviousNext

Posted May 07, 2023.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19

Luke Milross, Bethany Hunter, David McDonald, George Merces, Amanda Thompson, Catharien M.U. Hilkens, John Wills, Paul Rees, Kasim Jiwa, Nigel Cooper, Joaquim Majo, Helen Ashwin, Christopher J.A. Duncan, Paul M. Kaye, Omer Ali Bayraktar, Andrew Filby, Andrew J. Fisher

medRxiv 2023.05.05.23289594; doi: https://doi.org/10.1101/2023.05.05.23289594

Share This Article: